Emergent BioSolutions to Release Second Quarter 2024 Financial Results & Conduct Conference Call on August 6, 2024
July 23 2024 - 8:27AM
Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call
on Tuesday, August 6, 2024, at 5:00 pm eastern time to discuss the
financial results for the second quarter 2024, key business
updates, revenue guidance for the third quarter of 2024, as well as
full year guidance.
Conference Call InformationParticipants can
access the conference call live via webcast. To participate via
telephone, please register in advance at this link. Upon
registration, all telephone participants will receive a
confirmation email detailing how to join the conference call,
including the dial-in number along with a unique passcode and
registrant ID that can be used to access the call.
A replay of the call can be accessed from the Investors page of
Emergent’s website.
About Emergent BioSolutionsAt Emergent, our
mission is to protect and enhance life. For 25 years, we’ve been at
work defending people from things we hope will never happen—so we
are prepared just in case they ever do. We provide solutions for
complex and urgent public health threats through a portfolio of
vaccines and therapeutics that we develop and manufacture for
governments and consumers. We also offer a range of integrated
contract development and manufacturing services for pharmaceutical
and biotechnology customers. To learn more about how we plan to
protect or enhance 1 billion lives by 2030, visit
our website and follow us
on LinkedIn, X, Instagram, Apple
Podcasts and Spotify.
Investor Contact:Richard S.
LindahlExecutive Vice President,
CFOlindahlr@ebsi.com
Media Contact:Assal HellmerVice
President, Communicationsmediarelations@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Jul 2023 to Jul 2024